COPD
Conference Coverage
Pulmonologist consult at COPD admission reduces risk of return
“When stratified by severity of COPD at the time of admission, the difference in the readmission rate was even greater.”
Opinion
Global Initiative for Chronic Obstructive Lung Disease guidelines 2022: Management and treatment
According to the GOLD report, initial management of COPD should aim at reducing exposure to risk factors such as smoking or other chemical...
Feature
Mucus unplugged
Investigators seek balance between preserving mucus’s protective function and reducing oversecretion in inflammatory lung diseases.
Conference Coverage
Large trial of home-based COPD rehab shows positive results
Those assigned to the intervention had a significant and clinically meaningful improvement.
Feature
Climate change magnifies health effects of wildfire smoke in care deserts
About 5.5 million Americans live in the 488 counties where drive times to pulmonologists are an hour or more.
Conference Coverage
Lung volume reduction methods show similar results for emphysema
“Until now there had been no direct comparison of the two to inform decision-making.”
Conference Coverage
Biomarker-guided steroid therapy shown safe for COPD
“A personalized endotype-based treatment with oral prednisolone is possible in patients with COPD.”
Conference Coverage
RETHINC takes air out of COPD-like therapy for smokers
Bronchodilator therapy was no better than placebo at reducing respiratory symptoms in smokers without airway obstruction.
From the Journals
Sclerostin predicts exacerbations in COPD patients
Sclerostin is associated with bone metabolism and may play a role in “muscle-bone crosstalk.”
From the Journals
Home program improves some functional capacity in COPD
“Home-based programs became increasingly popular in the last years and complement traditional center-based inpatient and outpatient PR.”